Luis Sanchez, an expert in the Contract Research Organization (CRO) industry, shares his insights on Medpace Holdings. He discusses Medpace's strong position in managing clinical trials and how its unique business model offers advantages to smaller biotech firms. The conversation examines current trends in the biotech sector, including the impact of rising interest rates and regulatory changes. Sanchez also sheds light on Medpace's leadership style and company culture, plus explores the future integration of AI in clinical trials.